ArticleThe international journal of neuropsychopharmacology2017

Preclinical Evidence That 5-HT1B Receptor Agonists Show Promise as Medications for Psychostimulant Use Disorders.

Raul Garcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.